Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-30

Clinical Trial Update: Pilot Study of Magnesium Infusions in Pediatric Asthma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 pilot trial evaluating intravenous magnesium infusions for pediatric asthma has been withdrawn. No results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate infusion (magnesium sulfate)

Snippet

Sponsor: University of Louisville | Conditions: Asthma | Phase 2, Phase 3 | Status: WITHDRAWN